GV 2016 GP LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
GV 2016 GP LP
CIK #0001722201, 0001722204
EDGAR Form CIK 2011 - 2026
3 [0001722201]
4 [0001722201]
3 [0001722204]
4 [0001722204]
Form 3/4/5 Subject 2011 - 2026
Alphabet Inc
GV 2016 LP
Starco Brands Inc
GV 2016 GP LLC
GV 2016 GP LP
IonQ Inc
Decibel Therapeutics Inc
Dianthus Therapeutics Inc /DE/
Arcus Biosciences Inc
ARMO BioSciences Inc
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Starco Brands Inc STCB
Class A Common Stock
2025-05-15 Other 47,980,156
Starco Brands Inc STCB
Class A Common Stock
2024-02-15 Other 36,300,393
Starco Brands Inc STCB
Class A Common Stock
2024-02-14 Other 5,675,399
IonQ Inc IONQ
Common Stock
2022-04-11 Sell 539,257 $11.16 6,018,108
IonQ Inc IONQ
Common Stock
2022-04-11 Sell 4,992 $11.83 59,055
IonQ Inc IONQ
Common Stock
2022-04-11 Other 2,642,573 $0.00
Decibel Therapeutics Inc DBTX
Series A Preferred Stock · derivative
2021-02-17 Conversion 5,000,000
Decibel Therapeutics Inc DBTX
Common Stock
2021-02-17 Conversion 321,978
Dianthus Therapeutics Inc /DE/ MGTA
Series B Preferred Stock · derivative
2018-06-25 Conversion 8,494,864
Dianthus Therapeutics Inc /DE/ MGTA
Common Stock
2018-06-25 Conversion 3,339,137
Dianthus Therapeutics Inc /DE/ MGTA
Series A Preferred Stock · derivative
2018-06-25 Conversion 133,400
Arcus Biosciences Inc RCUS
Series B Convertible Preferred Stock · derivative
2018-03-19 Conversion 3,125,312
Arcus Biosciences Inc RCUS
Common Stock
2018-03-19 Conversion 3,125,312
ARMO BioSciences Inc ARMO
Series C-1 Convertible Preferred Stock · derivative
2018-01-30 Conversion 607,350
ARMO BioSciences Inc ARMO
Common Stock
2018-01-30 Conversion 607,350
X4 Pharmaceuticals Inc ASNS
Common Stock
2017-11-20 Conversion 451,362
X4 Pharmaceuticals Inc ASNS
Series D Convertible Preferred Stock · derivative
2017-11-20 Conversion 1,540,499
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com